Minapharm Pharmaceuticals Acquires Majority Stake in ProBioGen

Dr. Wieland Wolf Appointed New CEO

18-Jun-2010 - ProBioGen AG announced that Minapharm Pharmaceuticals, Cairo, has completed the acquisition of 95% of the share capital of ProBioGen, an internationally renowned German cell line development and contract manufacturing specialist. The total purchase price of EUR 30.4 million includes earn-out ...

Probiogen Signs Therapeutic Protein Process Development Contract With Virdante Pharmaceuticals

30-Apr-2010 - ProBioGen AG announced signing a contract with Virdante Biopharmaceuticals, Inc., a US-based biopharmaceutical development company. ProBioGen will contribute producer cell line development and process engineering for one of Virdante’s proprietary therapeutic proteins. Virdante’s protein ...

Patent granted for ProBioGen's avian cell line AGE1.CR

14-Jul-2008 - ProBioGen AG, a biotechnology company in cell engineering and production of biopharmaceuticals, has been granted patent protection for AGE1.CR, a proprietary duck cell line developed for the production of human and animal vaccines and proteins. The granted patent as parent, ProBioGen also claims ...

ProBioGen Announces Exclusive Licensing Agreement for its Proprietary Avian Cell Line AGE1.CR

Significant upfront and milestone payments plus royalties for four indications

10-Dec-2007 - ProBioGen AG announced the closing of an exclusive licensing agreement for its avian cell line AGE1.CR. The agreement was signed with an undisclosed US vaccine development company and covers a total of four indications, including different forms of influenza and three additional disease ...

ProBioGen and Minapharm Enter into Development and Co-promotion Agreements

24-Apr-2007 - ProBioGen and Minapharm jointly announced that they have entered into two separate agreements to develop two therapeutic proteins, one exclusively for Minapharm and another second generation biopharmaceutical product for co-promotion. In the first agreement, ProBioGen will apply its cell ...

Affitech contracts with ProBioGen for producer cell line generation for oncology antibody candidate

13-Apr-2007 - ProBioGen AG, and Affitech AS, jointly announced that they have entered into an agreement for a biopharmaceutical cell line to be developed by ProBioGen for high-level production of one of the lead candidates in Affitech's oncology therapeutic antibody pipeline. Under the terms of the agreement, ...

ProBioGen and Evotec Technologies Announce Successful Completion of Collaboration on Automated Cell Selection Technology

01-Sep-2006 - ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint evaluation of methods and instrumentation for the selection of high producer cells. ProBioGen could show based on it's cell-based assay technology, know how and expertise in cGMP ...

ProBioGen Signed Agreement on Testing of Neuronal Cell Lines with Serono

10-Apr-2006 - ProBioGen AG announced that Serono S.A., Switzerland has signed an agreement to evaluate ProBioGen's novel human neuronal cell line for the production of recombinant proteins. Under the terms of the Agreement, Serono will explore the feasibility of using the proprietary neuronal cell line of ...

ProBioGen and Saxonia BioTec to optimise new types of bioreactors for research and diagnostics

03-Dec-2004 - The internationally renowned specialist for mammalian cell lines ProBioGen AG, has established a long-term collaboration with Saxonia BioTec GmbH. The objective of this collaboration is to optimise a new generation of bioreactors developed by Saxonia. These will be tested by ProBioGen for the ...

ProBioGen enters into an evaluation programme with major vaccines company for the testing of cell lines

05-Oct-2004 - Berlin. ProBioGen AG announced that it has entered into a joint programme with Chiron Vaccines, a business unit of Chiron Corporation, to evaluate ProBioGen´s vaccine cell lines for vaccine production. Under the programme, ProBioGen will cultivate several of its new cell lines which have been ...